Which patients with relapsed non-Hodgkin's lymphoma benefit from high-dose therapy and hematopoietic stem-cell transplantation?
- PMID: 8105033
- DOI: 10.1200/JCO.1993.11.10.1841
Which patients with relapsed non-Hodgkin's lymphoma benefit from high-dose therapy and hematopoietic stem-cell transplantation?
Comment on
-
High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma.J Clin Oncol. 1993 Oct;11(10):1846-51. doi: 10.1200/JCO.1993.11.10.1846. J Clin Oncol. 1993. PMID: 8105034
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources